Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

GLP-1 medications that have helped people lose weight may also help people drink less alcohol, according to new ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank ...